Clinical Trial Matcher

NCT06711952

German Validation Study of the Subjective Cognitive Decline Questionnaire (SCD-Q)

Recruiting · Not Applicable · Ludwig-Maximilians - University of Munich · registry updated 2025-05-29

Inclusion and exclusion lines below are quoted from ClinicalTrials.gov. No match score is shown, because a score needs a person's age, biomarkers, and treatment dates. Confirm the record with the study team.

The SCD-Q (Subjective Cognitive Decline-Questionnaire) is an established instrument to quantify self-perceived cognitive decline. Both self- and informant-rated versions of the SCD-Q are available. However, the SCD-Q has not been validated in the German language yet. Hence, the investigators aim to validate the self-reported SCD-Q in a clinical sample in Germany.

Inclusion

  • Medical appointment for dementia diagnostics at the Alzheimer Therapie- und Forschungszentrum
  • Provision of signed, written and dated informed consent
  • Capacity to give informed consent

Exclusion

  • dementia in a very advance stage

Open NCT06711952 on ClinicalTrials.govAll conditions